Healthcare provider profile · identity verified

Alisha Ann Rust, D.O.

Family Practice · HIGHLAND HEIGHTS, KY · NPI 1336540905

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	436	129
Levothyroxine Sodium	Levothyroxine Sodium	260	80
Lisinopril	Lisinopril	228	70
Omeprazole	Omeprazole	185	56
Amlodipine Besylate	Amlodipine Besylate	157	49
Pantoprazole Sodium	Pantoprazole Sodium	152	47
Losartan Potassium	Losartan Potassium	146	46
Hydrochlorothiazide	Hydrochlorothiazide	140	43
Carvedilol	Carvedilol	134	41
Rosuvastatin Calcium	Rosuvastatin Calcium	126	42
Metoprolol Succinate	Metoprolol Succinate	123	42
Trazodone Hcl	Trazodone Hcl	122	37
Gabapentin	Gabapentin	115	28
Alendronate Sodium	Alendronate Sodium	111	31
Metformin Hcl	Metformin Hcl	96	31
Metformin Hcl Er	Metformin Hcl	91	27
Buspirone Hcl	Buspirone Hcl	87	23
Eliquis	Apixaban	87	19
Fluticasone Propionate	Fluticasone Propionate	86	39
Albuterol Sulfate Hfa	Albuterol Sulfate	84	35
Furosemide	Furosemide	82	26
Sertraline Hcl	Sertraline Hcl	81	23
Simvastatin	Simvastatin	76	24
Meloxicam	Meloxicam	75	22
Pravastatin Sodium	Pravastatin Sodium	75	23
Spironolactone	Spironolactone	72	18
Bupropion Xl	Bupropion Hcl	71	18
Potassium Chloride	Potassium Chloride	70	23
Ozempic	Semaglutide	69	19
Lorazepam	Lorazepam	66	17
Allopurinol	Allopurinol	64	22
Prednisone	Prednisone	63	57
Citalopram Hbr	Citalopram Hydrobromide	62	20
Ezetimibe	Ezetimibe	61	17
Glipizide	Glipizide	61	19
Metoprolol Tartrate	Metoprolol Tartrate	60	16
Duloxetine Hcl	Duloxetine Hcl	59	20
Fluoxetine Hcl	Fluoxetine Hcl	57	19
Montelukast Sodium	Montelukast Sodium	54	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	suppressed
Tizanidine Hcl	Tizanidine Hcl	51	suppressed
Diclofenac Sodium	Diclofenac Sodium	48	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	48	12
Paroxetine Hcl	Paroxetine Hcl	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	18
Atenolol	Atenolol	43	13
Donepezil Hcl	Donepezil Hcl	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	39	14
Venlafaxine Hcl Er	Venlafaxine Hcl	39	12
Pioglitazone Hcl	Pioglitazone Hcl	37	11
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Tramadol Hcl	Tramadol Hcl	35	11
Cephalexin	Cephalexin	34	24
Glimepiride	Glimepiride	34	12
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Valsartan	Valsartan	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Methocarbamol	Methocarbamol	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Eszopiclone	Eszopiclone	30	suppressed
Topiramate	Topiramate	30	suppressed
Ondansetron Odt	Ondansetron	28	13
Trulicity	Dulaglutide	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	13
Januvia	Sitagliptin Phosphate	26	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	26	12
Azithromycin	Azithromycin	25	23
Ibuprofen	Ibuprofen	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Diazepam	Diazepam	22	suppressed
Fluconazole	Fluconazole	22	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	14
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	11
Synthroid	Levothyroxine Sodium	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Jardiance	Empagliflozin	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Linzess	Linaclotide	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Finasteride	Finasteride	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Protriptyline Hcl	Protriptyline Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error